Cargando…

Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls

BACKGROUND: Life-long early ART (started before age 2 years), often with periods of treatment interruption, is now the standard of care in pediatric HIV infection. Although cross-sectional studies have investigated HIV-related differences in cortical morphology in the setting of early ART and ART in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nwosu, Emmanuel C., Holmes, Martha J., Cotton, Mark F., Dobbels, Els, Little, Francesca, Laughton, Barbara, van der Kouwe, Andre, Robertson, Frances, Meintjes, Ernesta M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951512/
https://www.ncbi.nlm.nih.gov/pubmed/36829110
http://dx.doi.org/10.1186/s12868-023-00783-7
_version_ 1784893403153039360
author Nwosu, Emmanuel C.
Holmes, Martha J.
Cotton, Mark F.
Dobbels, Els
Little, Francesca
Laughton, Barbara
van der Kouwe, Andre
Robertson, Frances
Meintjes, Ernesta M.
author_facet Nwosu, Emmanuel C.
Holmes, Martha J.
Cotton, Mark F.
Dobbels, Els
Little, Francesca
Laughton, Barbara
van der Kouwe, Andre
Robertson, Frances
Meintjes, Ernesta M.
author_sort Nwosu, Emmanuel C.
collection PubMed
description BACKGROUND: Life-long early ART (started before age 2 years), often with periods of treatment interruption, is now the standard of care in pediatric HIV infection. Although cross-sectional studies have investigated HIV-related differences in cortical morphology in the setting of early ART and ART interruption, the long-term impact on cortical developmental trajectories is unclear. This study compares the longitudinal trajectories of cortical thickness and folding (gyrification) from age 5 to 9 years in a subset of children perinatally infected with HIV (CPHIV) from the Children with HIV Early antiRetroviral therapy (CHER) trial to age-matched children without HIV infection. METHODS: 75 CHER participants in follow-up care at FAMCRU (Family Centre for Research with Ubuntu), as well as 66 age-matched controls, received magnetic resonance imaging (MRI) on a 3 T Siemens Allegra at ages 5, 7 and/or 9 years. MR images were processed, and cortical surfaces reconstructed using the FreeSurfer longitudinal processing stream. Vertex-wise linear mixed effects (LME) analyses were performed across the whole brain to compare the means and linear rates of change of cortical thickness and gyrification from 5 to 9 years between CPHIV and controls, as well as to examine effects of ART interruption. RESULTS: Children without HIV demonstrated generalized cortical thinning from 5 to 9 years, with the rate of thinning varying by region, as well as regional age-related gyrification increases. Overall, the means and developmental trajectories of cortical thickness and gyrification were similar in CPHIV. However, at an uncorrected p < 0.005, 6 regions were identified where the cortex of CPHIV was thicker than in uninfected children, namely bilateral insula, left supramarginal, lateral orbitofrontal and superior temporal, and right medial superior frontal regions. Planned ART interruption did not affect development of cortical morphometry. CONCLUSIONS: Although our results suggest that normal development of cortical morphometry between the ages of 5 and 9 years is preserved in CPHIV who started ART early, these findings require further confirmation with longitudinal follow-up through the vulnerable adolescent period. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12868-023-00783-7.
format Online
Article
Text
id pubmed-9951512
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99515122023-02-25 Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls Nwosu, Emmanuel C. Holmes, Martha J. Cotton, Mark F. Dobbels, Els Little, Francesca Laughton, Barbara van der Kouwe, Andre Robertson, Frances Meintjes, Ernesta M. BMC Neurosci Research BACKGROUND: Life-long early ART (started before age 2 years), often with periods of treatment interruption, is now the standard of care in pediatric HIV infection. Although cross-sectional studies have investigated HIV-related differences in cortical morphology in the setting of early ART and ART interruption, the long-term impact on cortical developmental trajectories is unclear. This study compares the longitudinal trajectories of cortical thickness and folding (gyrification) from age 5 to 9 years in a subset of children perinatally infected with HIV (CPHIV) from the Children with HIV Early antiRetroviral therapy (CHER) trial to age-matched children without HIV infection. METHODS: 75 CHER participants in follow-up care at FAMCRU (Family Centre for Research with Ubuntu), as well as 66 age-matched controls, received magnetic resonance imaging (MRI) on a 3 T Siemens Allegra at ages 5, 7 and/or 9 years. MR images were processed, and cortical surfaces reconstructed using the FreeSurfer longitudinal processing stream. Vertex-wise linear mixed effects (LME) analyses were performed across the whole brain to compare the means and linear rates of change of cortical thickness and gyrification from 5 to 9 years between CPHIV and controls, as well as to examine effects of ART interruption. RESULTS: Children without HIV demonstrated generalized cortical thinning from 5 to 9 years, with the rate of thinning varying by region, as well as regional age-related gyrification increases. Overall, the means and developmental trajectories of cortical thickness and gyrification were similar in CPHIV. However, at an uncorrected p < 0.005, 6 regions were identified where the cortex of CPHIV was thicker than in uninfected children, namely bilateral insula, left supramarginal, lateral orbitofrontal and superior temporal, and right medial superior frontal regions. Planned ART interruption did not affect development of cortical morphometry. CONCLUSIONS: Although our results suggest that normal development of cortical morphometry between the ages of 5 and 9 years is preserved in CPHIV who started ART early, these findings require further confirmation with longitudinal follow-up through the vulnerable adolescent period. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12868-023-00783-7. BioMed Central 2023-02-24 /pmc/articles/PMC9951512/ /pubmed/36829110 http://dx.doi.org/10.1186/s12868-023-00783-7 Text en © The Author(s) 2023, corrected publication 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Nwosu, Emmanuel C.
Holmes, Martha J.
Cotton, Mark F.
Dobbels, Els
Little, Francesca
Laughton, Barbara
van der Kouwe, Andre
Robertson, Frances
Meintjes, Ernesta M.
Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls
title Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls
title_full Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls
title_fullStr Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls
title_full_unstemmed Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls
title_short Similar cortical morphometry trajectories from 5 to 9 years in children with perinatal HIV who started treatment before age 2 years and uninfected controls
title_sort similar cortical morphometry trajectories from 5 to 9 years in children with perinatal hiv who started treatment before age 2 years and uninfected controls
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951512/
https://www.ncbi.nlm.nih.gov/pubmed/36829110
http://dx.doi.org/10.1186/s12868-023-00783-7
work_keys_str_mv AT nwosuemmanuelc similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols
AT holmesmarthaj similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols
AT cottonmarkf similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols
AT dobbelsels similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols
AT littlefrancesca similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols
AT laughtonbarbara similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols
AT vanderkouweandre similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols
AT robertsonfrances similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols
AT meintjesernestam similarcorticalmorphometrytrajectoriesfrom5to9yearsinchildrenwithperinatalhivwhostartedtreatmentbeforeage2yearsanduninfectedcontrols